Vol 2 (April 30, 2021): Translational Breast Cancer Research

Case Report 
A case report of primary squamous cell carcinoma of the breast
Xiaoli Yao, Huihua He, Jingping Yuan, Feng Yao
Translational Breast Cancer Research  
2021;
2:
16  
Case Report 
T-DM1 for advanced breast cancer after multi-anti-HER2-target therapy: a case report
Langshuang Sun, Lu Gan, Tao Wang
Translational Breast Cancer Research  
2021;
2:
15  
Case Report 
Benefit with re-challenge of immune checkpoint inhibitors in patient with metastatic triple-negative breast cancer: a case report
Jinmei Zhou, Tao Wang, Li Bian, Jianbin Li, Zefei Jiang
Translational Breast Cancer Research  
2021;
2:
14  
Review Article 
Cyclin-dependent kinase 4 and 6 inhibitors at the crossroads: the combinational therapeutic strategies in breast cancer—a narrative review
Yiqi Yang, Sha Zhu, Ziyi Fu, Chunxiao Sun, Fan Yang, Tianyu Zeng, Yijia Hua, Shengnan Bao, Xian Gao, Xiang Huang, Wei Li, Yongmei Yin
Translational Breast Cancer Research  
2021;
2:
13  
Review Article 
Potential biomarkers of resistance to CDK4/6 inhibitors: a narrative review of preclinical and clinical studies
Weiyi Huang, Hongxia Wang
Translational Breast Cancer Research  
2021;
2:
12  
Original Article 
The role of FOXP3 of interstitial tissue in the pathogenesis of breast cancer
Yu-Juan Xiang, Man Feng, Li-Yuan Liu, Fei Wang, Li-Xiang Yu, Fei Zhou, Shu-Ya Huang, Chao Zheng, Chun-Miao Ye, Wen-Zhong Zhou, Geng-Shen Yin, Zhong-Bing Ma, Liang Li, Qiang Zhang, Qin-Ye Fu, Zhi-Gang Yu
Translational Breast Cancer Research  
2021;
2:
11  
Editorial 
How bone metastases can influence the management of breast cancer
T. John Martin
Translational Breast Cancer Research  
2021;
2:
10